Home › Funds › Ghisallo Capital Management LLC › CYTK

Ghisallo Capital Management LLC position in CYTK

CYTOKINETICS INC · Health Care

Ghisallo Capital Management LLC reported holding 170,000 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$11.2M, representing 0.26% of its reported portfolio and ranking #48 among its reported holdings. Ghisallo Capital Management LLC has disclosed CYTK holdings in 3 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)170.00K sh
Reported value held$11.20M
Portfolio Weight0.26%
First reportedQ2 2024
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Ghisallo Capital Management LLC's CYTK position evolved

Ghisallo Capital Management LLC first disclosed a stake in CYTK in Q2 2024 at 196,000 shares (US$10.6M). The position peaked in Q2 2026 at 170,000 shares, worth US$14.5M. Across 3 filings, Ghisallo Capital Management LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 170,000 shares valued at US$11.2M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 196.00K $10.62M New
Q2 2026 170.00K $14.48M New
Q3 2026 170.00K $11.20M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 40 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Ghisallo Capital Management LLC held CYTK?

Ghisallo Capital Management LLC has disclosed CYTK holdings in 3 of the last 10 reported quarters, going back to Q2 2024.

What is Ghisallo Capital Management LLC's current position in CYTK?

As of Q3 2026, Ghisallo Capital Management LLC holds 170.00K shares of CYTK (CYTOKINETICS INC), valued at $11.20M, representing 0.26% of its reported portfolio and ranking #48.

Has Ghisallo Capital Management LLC been buying or selling CYTK?

In the latest 13F filing (Q3 2026), Ghisallo Capital Management LLC held unchanged its position in CYTK. The position peaked in Q2 2026 at 170.00K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.